481 related articles for article (PubMed ID: 22927820)
1. Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas.
Haecker I; Gay LA; Yang Y; Hu J; Morse AM; McIntyre LM; Renne R
PLoS Pathog; 2012; 8(8):e1002884. PubMed ID: 22927820
[TBL] [Abstract][Full Text] [Related]
2. Modified Cross-Linking, Ligation, and Sequencing of Hybrids (qCLASH) Identifies Kaposi's Sarcoma-Associated Herpesvirus MicroRNA Targets in Endothelial Cells.
Gay LA; Sethuraman S; Thomas M; Turner PC; Renne R
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386283
[TBL] [Abstract][Full Text] [Related]
3. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
4. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines.
Gottwein E; Corcoran DL; Mukherjee N; Skalsky RL; Hafner M; Nusbaum JD; Shamulailatpam P; Love CL; Dave SS; Tuschl T; Ohler U; Cullen BR
Cell Host Microbe; 2011 Nov; 10(5):515-26. PubMed ID: 22100165
[TBL] [Abstract][Full Text] [Related]
5. Identification of Target Genes Regulated by KSHV miRNAs in KSHV-Infected Lymphoma Cells.
Quan L; Qiu T; Liang J; Li M; Zhang Y; Tao K
Pathol Oncol Res; 2015 Sep; 21(4):875-80. PubMed ID: 25648438
[TBL] [Abstract][Full Text] [Related]
6. Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells.
Viollet C; Davis DA; Reczko M; Ziegelbauer JM; Pezzella F; Ragoussis J; Yarchoan R
PLoS One; 2015; 10(5):e0126439. PubMed ID: 25942495
[TBL] [Abstract][Full Text] [Related]
7. miRNAs and their roles in KSHV pathogenesis.
Hussein HAM; Alfhili MA; Pakala P; Simon S; Hussain J; McCubrey JA; Akula SM
Virus Res; 2019 Jun; 266():15-24. PubMed ID: 30951791
[TBL] [Abstract][Full Text] [Related]
8. Functional dissection of human targets for KSHV-encoded miRNAs using network analysis.
Wang Y; Lin Y; Guo Y; Pu X; Li M
Sci Rep; 2017 Jun; 7(1):3159. PubMed ID: 28600495
[TBL] [Abstract][Full Text] [Related]
9. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
[TBL] [Abstract][Full Text] [Related]
10. microRNA dependent and independent deregulation of long non-coding RNAs by an oncogenic herpesvirus.
Sethuraman S; Gay LA; Jain V; Haecker I; Renne R
PLoS Pathog; 2017 Jul; 13(7):e1006508. PubMed ID: 28715488
[TBL] [Abstract][Full Text] [Related]
11. Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies.
Chugh PE; Sin SH; Ozgur S; Henry DH; Menezes P; Griffith J; Eron JJ; Damania B; Dittmer DP
PLoS Pathog; 2013; 9(7):e1003484. PubMed ID: 23874201
[TBL] [Abstract][Full Text] [Related]
12. Proteomic screening of human targets of viral microRNAs reveals functions associated with immune evasion and angiogenesis.
Gallaher AM; Das S; Xiao Z; Andresson T; Kieffer-Kwon P; Happel C; Ziegelbauer J
PLoS Pathog; 2013; 9(9):e1003584. PubMed ID: 24039573
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA.
Tagawa T; Gao S; Koparde VN; Gonzalez M; Spouge JL; Serquiña AP; Lurain K; Ramaswami R; Uldrick TS; Yarchoan R; Ziegelbauer JM
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12805-12810. PubMed ID: 30455306
[TBL] [Abstract][Full Text] [Related]
14. Evidence for Multiple Subpopulations of Herpesvirus-Latently Infected Cells.
Landis JT; Tuck R; Pan Y; Mosso CN; Eason AB; Moorad R; Marron JS; Dittmer DP
mBio; 2022 Feb; 13(1):e0347321. PubMed ID: 35089062
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.
Paul AG; Chandran B; Sharma-Walia N
Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332
[TBL] [Abstract][Full Text] [Related]
16. Viral MicroRNAs Repress the Cholesterol Pathway, and 25-Hydroxycholesterol Inhibits Infection.
Serquiña AKP; Kambach DM; Sarker O; Ziegelbauer JM
mBio; 2017 Jul; 8(4):. PubMed ID: 28698273
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells.
Cai X; Lu S; Zhang Z; Gonzalez CM; Damania B; Cullen BR
Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5570-5. PubMed ID: 15800047
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9 ablating viral microRNA promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus.
Liang Z; Qin Z; Riker AI; Xi Y
Biochem Biophys Res Commun; 2020 Dec; 533(4):1400-1405. PubMed ID: 33092788
[TBL] [Abstract][Full Text] [Related]
19. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
20. Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional
Park A; Oh S; Jung KL; Choi UY; Lee HR; Rosenfeld MG; Jung JU
Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21618-21627. PubMed ID: 32817485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
